TAF4-FAF1 Fusion FISH Probe
The TAF4-FAF1 Fusion FISH Probe is used to confirm a fusion of the TAF4 and FAF1 genes. The fusion of the TAF4 and FAF1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TAF4-FAF1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TAF4-FAF1-20-AQAQ | 20 (40 μL) | 200 μL |
|
TAF4 Gene Summary
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that has been shown to potentiate transcriptional activation by retinoic acid, thyroid hormone and vitamin D3 receptors. In addition, this subunit interacts with the transcription factor CREB, which has a glutamine-rich activation domain, and binds to other proteins containing glutamine-rich regions. Aberrant binding to this subunit by proteins with expanded polyglutamine regions has been suggested as one of the pathogenetic mechanisms underlying a group of neurodegenerative disorders referred to as polyglutamine diseases. [provided by RefSeq, Jul 2008]
Gene Name: TATA-box Binding Protein Associated Factor 4
Chromosome: CHR20: 60549853 -60640866
Locus: 20q13.33
FAF1 Gene Summary
Interaction of Fas ligand (TNFSF6) with the FAS antigen (TNFRSF6) mediates programmed cell death, also called apoptosis, in a number of organ systems. The protein encoded by this gene binds to FAS antigen and can initiate apoptosis or enhance apoptosis initiated through FAS antigen. Initiation of apoptosis by the protein encoded by this gene requires a ubiquitin-like domain but not the FAS-binding domain. [provided by RefSeq, Jul 2008]
Gene Name: Fas Associated Factor 1
Chromosome: CHR1: 50906934 -51425936
Locus: 1p32.3
Gene Diseases
The TAF4 FAF1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|